Skip to content

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04753385
Acronym
UNCOVER
Enrollment
138
Registered
2021-02-15
Start date
2021-03-23
Completion date
2024-09-06
Last updated
2024-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment Resistant Depression

Keywords

Depression, TRD

Brief summary

The objective of this study is to collect both active and passive data using a wearable, multi-sensor device (Verily Study Watch) and phone application (Mood App) which aims to capture mental health status, in subjects participating in the RECOVER clinical trial (A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression).

Detailed description

A prospective, observational, exploratory study collecting passive and active behavioral, environmental and physiological data, via the use of an Android smartphone application and Study Watch. This sub-study is only open to sites participating in the RECOVER clinical study. All subjects participating in the RECOVER clinical trial at active UNCOVER sites will be offered participation in this sub-study. Subjects who opt-in to the Mood App portion of the sub-study will be followed for a minimum of 12 months and a maximum of 60 months for the Mood App portion of the sub-study. Subjects who opt-in to the use of the Study Watch portion of the sub-study will be followed for a minimum of 12 months and maximum of 24 months for the Study Watch portion of the sub-study.

Interventions

None listed

Sponsors

LivaNova
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All Subjects 1. Current consented subject in the RECOVER clinical trial; 2. Adult (i.e. ≥ 18 years of age, unless a resident of any U.S. state where the age of majority is 19, in which case must be ≥ 19 years of age); 3. Able and willing to provide written informed consent for this sub-study; 4. Able and willing to comply with all study procedures; 5. Able to read and speak English. Phone Application 1. Have a personal Google user account or be willing to create and own a personal Google user account; 2. Owns a personal Android smartphone with a data plan and is the sole user of that smartphone; 3. Agrees to download and maintain the phone application onto personal Android smartphone for the duration of the sub-study; Study Watch 1\. Willing to comply with Study Watch wearing and recharging requirements

Exclusion criteria

All Subjects 1\. Any condition or situation the Principal Investigator determines as inappropriate for study inclusion Phone Application No additional

Design outcomes

Primary

MeasureTime frameDescription
Percentage of PHQ-8 tasksThrough study completion; Average 2 yearsPercentage of PHQ-8 tasks completed over the duration of the study
Percentage of Voice Diary tasksThrough study completion; Average 2 yearsPercentage of Voice Diary tasks completed over the duration of the study
Number of ping sensor recordingsThrough study completion; Average 2 yearsNumber of ping sensor recordings over the duration of the study
Number of hours of watch wear timeThrough study completion; Average 2 yearsNumber of hours of watch wear time over the duration of the study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026